FRANK J.M. TEN BRINK - Corporate Board Profile

Accelerate Diagnostics, Inc

Filing Date	Source Excerpt
2013-11-05	The Board maintains a standing Audit Committee comprised of Mr. ten Brink (Chairman), Mr. Schuler and Dr. Strobeck.
2014-04-15	Frank J.M. ten Brink 57 Director Frank J.M. ten Brink 765,077 Includes (i) initial award of option to purchase 134,011 shares of common stock at an exercise price of $6.48 per share, which vests 20% per year over a five-year period with the first installment vesting on March 5, 2014 and (ii) annual award of option to purchase 44,670 shares of common stock at an exercise price of $6.48 per share, which vests in 12 equal monthly installments with the first installment vesting on May 3, 2013.
2015-04-08	Frank J.M. ten Brink has served as a Director of the Company since March 6, 2013. Mr. ten Brink currently serves as Senior Vice President of Mergers and Acquisitions at Stericycle, Inc. (NASDAQ: SRCL) where he also served as Executive Vice President, Chief Financial Officer and Chief Administrative Officer from June 1997 to August 2014. He has over 16 years of finance experience in high growth environments, mergers and acquisitions. Prior to joining Stericycle, he was Senior Vice President and Chief Financial Officer with Telular Corporation. Between 1991 and 1995, he was Vice President and Chief Financial Officer of Hexacomb Corporation. Mr. ten Brink studied International Business at the Netherlands School of Business and received an M.B.A. degree in Finance from the University of Oregon.
2016-04-01	Frank J.M. ten Brink 59 Director The Board maintains a standing Audit Committee comprised of Mr. ten Brink (Chairman), Mr. Schuler and Dr. Strobeck. The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink.
2017-04-10	Frank J.M. ten Brink 60 Director ...The Board maintains a standing Audit Committee comprised of Mr. ten Brink (Chairman), Mr. Schuler and Dr. Strobeck. ...The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink. ...The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2016: Frank J.M. ten Brink 79,519 79,519
2018-04-12	The Board maintains a standing Audit Committee comprised of Mr. ten Brink (Chairman), Mr. Schuler and Dr. Strobeck. Each member of the Audit Committee satisfies the independence standards specified in Rule 5605(a)(2) of the NASDAQ Listing Rules and the related rules of the SEC and has been determined by the Board to be “financially literate” with accounting or related financial management experience. The Board has also determined that Mr. ten Brink is an “audit committee financial expert” as defined under SEC rules and regulations, and qualifies as a financially sophisticated audit committee member as required under Rule 5605(c)(2)(A) of the NASDAQ Listing Rules. The Audit Committee has a written charter, a copy of which is available online at http://acceleratediagnostics.com/investors/corporate-governance/. The Audit Committee met 5 times during the year ended December 31, 2017. The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2017: Frank J.M. ten Brink Option Award(1) ($) 161,802 Total ($) 161,802
2019-04-05	Frank J.M. ten Brink has served as a Director of the Company since March 6, 2013. The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck. The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2018: Frank J.M. ten Brink (9) 115,667(2) 115,667 As of December 31, 2018, Mr. ten Brink held 230,145 options to purchase shares of our common stock.
2020-04-01	Frank J.M. ten Brink has served as a Director of the Company since March 6, 2013. ... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2019: Frank J.M. ten Brink (12) Option Award (1) ($) 133,904 Total ($) 133,904
2021-04-05	Frank J.M. ten Brink 64 Director... The Board has affirmatively determined that directors... ten Brink... are independent directors... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman) and Miller and Dr. Strobeck... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2020: Frank J.M. ten Brink 58,254 58,254
2022-04-07	Frank J.M. ten Brink has served as a Director of the Company since March 6, 2013. ... The Board has affirmatively determined that directors ... ten Brink ... are “independent directors” ... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman), Burris, Miller and Dr. Strobeck. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2021: Frank J.M. ten Brink 140,799